Cargando…
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590295/ https://www.ncbi.nlm.nih.gov/pubmed/36264840 http://dx.doi.org/10.15585/mmwr.mm7142a4 |
| _version_ | 1784814482186305536 |
|---|---|
| author | Britton, Amadea Embi, Peter J. Levy, Matthew E. Gaglani, Manjusha DeSilva, Malini B. Dixon, Brian E. Dascomb, Kristin Patel, Palak Schrader, Kristin E. Klein, Nicola P. Ong, Toan C. Natarajan, Karthik Hartmann, Emily Kharbanda, Anupam B. Irving, Stephanie A. Dickerson, Monica Dunne, Margaret M. Raiyani, Chandni Grannis, Shaun J. Stenehjem, Edward Zerbo, Ousseny Rao, Suchitra Han, Jungmi Sloan-Aagard, Chantel Griggs, Eric P. Weber, Zachary A. Murthy, Kempapura Fadel, William F. Grisel, Nancy McEvoy, Charlene Lewis, Ned Barron, Michelle A. Nanez, Juan Reese, Sarah E. Mamawala, Mufaddal Valvi, Nimish R. Arndorfer, Julie Goddard, Kristin Yang, Duck-Hye Fireman, Bruce Ball, Sarah W. Link-Gelles, Ruth Naleway, Allison L. Tenforde, Mark W. |
| author_facet | Britton, Amadea Embi, Peter J. Levy, Matthew E. Gaglani, Manjusha DeSilva, Malini B. Dixon, Brian E. Dascomb, Kristin Patel, Palak Schrader, Kristin E. Klein, Nicola P. Ong, Toan C. Natarajan, Karthik Hartmann, Emily Kharbanda, Anupam B. Irving, Stephanie A. Dickerson, Monica Dunne, Margaret M. Raiyani, Chandni Grannis, Shaun J. Stenehjem, Edward Zerbo, Ousseny Rao, Suchitra Han, Jungmi Sloan-Aagard, Chantel Griggs, Eric P. Weber, Zachary A. Murthy, Kempapura Fadel, William F. Grisel, Nancy McEvoy, Charlene Lewis, Ned Barron, Michelle A. Nanez, Juan Reese, Sarah E. Mamawala, Mufaddal Valvi, Nimish R. Arndorfer, Julie Goddard, Kristin Yang, Duck-Hye Fireman, Bruce Ball, Sarah W. Link-Gelles, Ruth Naleway, Allison L. Tenforde, Mark W. |
| author_sort | Britton, Amadea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9590295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95902952022-10-31 Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 Britton, Amadea Embi, Peter J. Levy, Matthew E. Gaglani, Manjusha DeSilva, Malini B. Dixon, Brian E. Dascomb, Kristin Patel, Palak Schrader, Kristin E. Klein, Nicola P. Ong, Toan C. Natarajan, Karthik Hartmann, Emily Kharbanda, Anupam B. Irving, Stephanie A. Dickerson, Monica Dunne, Margaret M. Raiyani, Chandni Grannis, Shaun J. Stenehjem, Edward Zerbo, Ousseny Rao, Suchitra Han, Jungmi Sloan-Aagard, Chantel Griggs, Eric P. Weber, Zachary A. Murthy, Kempapura Fadel, William F. Grisel, Nancy McEvoy, Charlene Lewis, Ned Barron, Michelle A. Nanez, Juan Reese, Sarah E. Mamawala, Mufaddal Valvi, Nimish R. Arndorfer, Julie Goddard, Kristin Yang, Duck-Hye Fireman, Bruce Ball, Sarah W. Link-Gelles, Ruth Naleway, Allison L. Tenforde, Mark W. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-10-21 /pmc/articles/PMC9590295/ /pubmed/36264840 http://dx.doi.org/10.15585/mmwr.mm7142a4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Britton, Amadea Embi, Peter J. Levy, Matthew E. Gaglani, Manjusha DeSilva, Malini B. Dixon, Brian E. Dascomb, Kristin Patel, Palak Schrader, Kristin E. Klein, Nicola P. Ong, Toan C. Natarajan, Karthik Hartmann, Emily Kharbanda, Anupam B. Irving, Stephanie A. Dickerson, Monica Dunne, Margaret M. Raiyani, Chandni Grannis, Shaun J. Stenehjem, Edward Zerbo, Ousseny Rao, Suchitra Han, Jungmi Sloan-Aagard, Chantel Griggs, Eric P. Weber, Zachary A. Murthy, Kempapura Fadel, William F. Grisel, Nancy McEvoy, Charlene Lewis, Ned Barron, Michelle A. Nanez, Juan Reese, Sarah E. Mamawala, Mufaddal Valvi, Nimish R. Arndorfer, Julie Goddard, Kristin Yang, Duck-Hye Fireman, Bruce Ball, Sarah W. Link-Gelles, Ruth Naleway, Allison L. Tenforde, Mark W. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 |
| title | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 |
| title_full | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 |
| title_fullStr | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 |
| title_full_unstemmed | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 |
| title_short | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 |
| title_sort | effectiveness of covid-19 mrna vaccines against covid-19–associated hospitalizations among immunocompromised adults during sars-cov-2 omicron predominance — vision network, 10 states, december 2021—august 2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590295/ https://www.ncbi.nlm.nih.gov/pubmed/36264840 http://dx.doi.org/10.15585/mmwr.mm7142a4 |
| work_keys_str_mv | AT brittonamadea effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT embipeterj effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT levymatthewe effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT gaglanimanjusha effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT desilvamalinib effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT dixonbriane effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT dascombkristin effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT patelpalak effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT schraderkristine effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT kleinnicolap effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT ongtoanc effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT natarajankarthik effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT hartmannemily effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT kharbandaanupamb effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT irvingstephaniea effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT dickersonmonica effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT dunnemargaretm effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT raiyanichandni effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT grannisshaunj effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT stenehjemedward effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT zerboousseny effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT raosuchitra effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT hanjungmi effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT sloanaagardchantel effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT griggsericp effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT weberzacharya effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT murthykempapura effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT fadelwilliamf effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT griselnancy effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT mcevoycharlene effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT lewisned effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT barronmichellea effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT nanezjuan effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT reesesarahe effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT mamawalamufaddal effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT valvinimishr effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT arndorferjulie effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT goddardkristin effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT yangduckhye effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT firemanbruce effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT ballsarahw effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT linkgellesruth effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT nalewayallisonl effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 AT tenfordemarkw effectivenessofcovid19mrnavaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsduringsarscov2omicronpredominancevisionnetwork10statesdecember2021august2022 |